International Journal of Radiation Oncology*Biology*Physics
Clinical InvestigationMinimized Doses for Linear Accelerator Radiosurgery of Brainstem Metastasis
Introduction
Treatment of cerebral metastases located inside the brainstem remains a challenge as the brainstem is considered to be a neurological organ at risk 1, 2. Surgery in this area, despite improvements in microsurgical techniques and neuronavigation, is still risky and is mainly restricted to superficial lesions in contact with the fourth ventricle. When radiotherapy is planned, effectiveness is limited because high doses are excluded to avoid neurological deterioration 2, 3, 4, 5.
Radiosurgery, therefore has an increasing place in treatment strategy for cerebral metastases 6, 7, 8. To date, very few series of patients treated for brainstem lesions have been reported; the doses delivered were equivalent to those used for supratentorial locations, despite the debated tolerance of irradiation to this area 9, 10, 11, 12, 13, 14, 15. In fact, there are no guidelines indicating which dose should be delivered to avoid adverse effects resulting from brainstem injury.
We report a retrospective study of 30 consecutive patients treated in our institution between 2005 and 2007 for brainstem metastases with micromultileaf LINAC radiosurgery, with reduced doses compared with those usually reported in the literature.
Section snippets
Patients
Selection of patients, who were treated consecutively, was based on life expectancy (>3 months), general status (Karnofsky Index [KI] >50), and number (fewer than four lesions) and size (<4 cm diameter) of brain lesions. Patients were hospitalized for 3 days. Corticosteroids were administered intravenously the day of treatment. Clinical and magnetic resonance imaging (MRI) follow-up was performed at 1 month, then every 3 months. A tumor was considered as controlled if its volume was stable or
Results
Thirty patients were treated from 2005 to 2007. Mean follow-up was 311 days (range, 41–1351). Median duration between treatment of primary and radiosurgery was 645 days (range, 17–3,484). Median patient age was 57 (range, 37–82). Of the patients, 20 were men and 10 women. Karnofsky index, recursive partitioning analysis (RPA), score index of radiosurgery (SIR), and basic score for brain metastases (BS-BM) are described in Table 1 16, 17, 18.
Primary tumor site was lung (n = 13), breast (n = 4),
Discussion
Brainstem metastases remain a therapeutic challenge because of the brainstem's life-maintaining functions. A space-occupying process in this area can easily induce intracranial hypertension or neurological impairment. Moreover, brainstem lesions are considered to be rapidly lethal when not controlled. Therefore, local control may have a strong influence on survival, but available data are still contradictory 9, 10, 11, 12, 13, 14, 15. For Hussain et al. (11), local control rate was 100% for a
Conclusion
Brainstem metastases are known to be challenging lesions. They are difficult to control with conventional treatments but nevertheless require optimized local control before a significant influence on patient survival can be achieved. In our study, we show that reduced doses, compared with those usually administered, can achieve the same local control of brainstem lesions with no side effects. This could well minimize the risk of neurological deterioration, and could lead to possibilities for
References (29)
- et al.
Stereotactic biopsy of brain stem masses: Decision analysis and literature review
Surg Neurol
(2006) - et al.
The integral biologically effective dose to predict brain stem toxicity of hypofractionated stereotactic radiotherapy
Int J Radiat Oncol Biol Phys
(1998) - et al.
Tolerance of normal tissue to therapeutic irradiation
Int J Radiat Oncol Biol Phys
(1991) - et al.
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05
Int J Radiat Oncol Biol Phys
(2000) - et al.
Radiosurgery for patients with brain metastases: A multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method
Int J Radiat Oncol Biol Phys
(2001) - et al.
Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases
Int J Radiat Oncol Biol Phys
(2000) - et al.
Stereotactic radiosurgery for brainstem metastases: Survival, tumor control, and patient outcomes
Int J Radiat Oncol Biol Phys
(2007) - et al.
Brain stem metastases treated with radiosurgery: Prognostic factors of survival and life expectancy estimation
Surg Neurol
(2009) - et al.
Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases
Int J Radiat Oncol Biol Phys
(2000) - et al.
Radiosurgery for brain metastases: A score index for predicting prognosis
Int J Radiat Oncol Biol Phys
(2000)
First-line radiosurgery of brain metastases. Interest and results of reduced dose
Neurochirurgie
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
Int J Radiat Oncol Biol Phys
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole brain radiation therapy: A randomized controlled trial
Lancet Oncol
Brainstem and trigeminal nerve changes after radiosurgery for trigeminal pain
Surg Neurol
Cited by (35)
Clinical and radiographic adverse events after Gamma Knife radiosurgery for brainstem lesions: A dosimetric analysis
2020, Radiotherapy and OncologyLinac-Based Fractionated Stereotactic Radiotherapy with a Micro-Multileaf Collimator for Brainstem Metastasis
2019, World NeurosurgeryCitation Excerpt :To enhance the management of metastatic brain tumors in the modern era, SRS and radiotherapy using radiosurgical modalities such as GK, CK, and Novalis have been developed to provide excellent local control with less toxicity in lieu of WBRT. Previous studies examining SRS or fSRT for BSM are summarized in Table 4.11-34 Huang et al.11 first assessed SRS for BSMs using GK in 1999.
Stereotactic radiotherapy of brain metastases in complex situations
2019, Cancer/RadiotherapieToxicity of Radiosurgery for Brainstem Metastases
2018, World NeurosurgeryCitation Excerpt :Stereotactic radiosurgery (SRS) for brainstem metastases (BSM) has been shown to be a safe and effective modality.1-31 Reported rates of local tumor control in patients who received SRS for BSM vary from 74% to 100%, and the median survival ranges from 4 to 12 months.1-28,30,31 Despite the promising results of SRS with respect to local control and survival, toxicity due to radiation is always a concern, with severe to life-threatening toxicities being reported in 0%–9.5% of patients with BSM treated with SRS.2-10,12-14,16-18,20-28,30,31
Stereotactic Radiosurgery for Brainstem Metastases: An International Cooperative Study to Define Response and Toxicity
2016, International Journal of Radiation Oncology Biology PhysicsCitation Excerpt :This realization has led some to use lower doses that are potentially ineffective for tumor control. Some reports of severe toxicity after brainstem SRS margin doses >16 Gy have led some authors to recommend avoiding doses this high (18, 26). Because of the small sample sizes, there was limited statistical power to associate SRS brainstem toxicity with tumor volume, location, margin dose, or previous WBRT.
Conflict of interest: none.